| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Ives Jeffrey L. is a Director at Tvardi Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $862K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2023 | ABOS Acumen Pharmaceuticals, Inc. | Director | Sale+OE | 41,949 | $6.49 | $272,333.52 | -100% | -63.0% | -59.8% | |
| Jul 15, 2022 | TVRD Tvardi Therapeutics, Inc. | Director | Sell | 3,600 | $9.05 | $32,580.00 | -18.9% | +7.9% | -69.1% | |
| Nov 12, 2021 | TVRD Tvardi Therapeutics, Inc. | Director | Sell | 8,180 | $16.04 | $131,207.20 | -53.2% | -35.7% | -31.8% | |
| Jun 7, 2021 | TVRD Tvardi Therapeutics, Inc. | Director | Sell | 2,520 | $13.05 | $32,886.00 | -14.1% | +16.0% | -34.1% | |
| Jun 1, 2020 | TVRD Tvardi Therapeutics, Inc. | Director | Sale+OE | 1,000 | $16.00 | $16,000.00 | -14.3% | - | - | |
| May 12, 2020 | TVRD Tvardi Therapeutics, Inc. | Director | Sale+OE | 2,500 | $16.00 | $40,000.00 | -29.4% | - | - | |
| Apr 21, 2020 | TVRD Tvardi Therapeutics, Inc. | Director | Sale+OE | 2,500 | $16.00 | $40,000.00 | -29.4% | - | - | |
| Mar 4, 2020 | TVRD Tvardi Therapeutics, Inc. | Director | Sale+OE | 2,500 | $16.00 | $40,000.00 | -29.4% | - | - | |
| Feb 3, 2020 | TVRD Tvardi Therapeutics, Inc. | Director | Sale+OE | 2,500 | $16.23 | $40,575.00 | -29.4% | - | - | |
| Jan 2, 2020 | TVRD Tvardi Therapeutics, Inc. | Director | Sale+OE | 2,500 | $16.13 | $40,325.00 | -29.4% | - | - |